Practice guidelines on the use of erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia

On July 1st 2009, a panel of experts met with the goal to provide a joint medical opinion on the use of erythropoiesis-stimulating agents (ESAs) in chemotherapy-induced anemia (CIA), as well as a joint proposal for revised reimbursement criteria in Belgium. The goal is to provide a clear and workable guidance on the use of ESAs in their registrered indication : chemotherapy induced anemia in cancer patients. An overview of participating experts can be found in Table 1.